Uniprot AC	Entrez ID	Gene Name	Disease	Cell Type	PTM Type	State	Position	PMID
Q04695	3872	KRT17	Uterine corpus endometrial carcinoma		Phosphorylation	N	S17	
Q04695	3872	KRT17	Uterine corpus endometrial carcinoma		Phosphorylation	N	S18	
Q04695	3872	KRT17	Glioblastoma multiforme		Phosphorylation	N	S24	
Q04695	3872	KRT17	Uterine corpus endometrial carcinoma		Phosphorylation	N	S24	
Q04695	3872	KRT17	Glioblastoma multiforme		Phosphorylation	N	T27	
Q04695	3872	KRT17	Uterine corpus endometrial carcinoma		Phosphorylation	N	T27	
Q04695	3872	KRT17	Glioblastoma multiforme		Phosphorylation	N	S28	
Q04695	3872	KRT17	Uterine corpus endometrial carcinoma		Phosphorylation	N	S28	
Q04695	3872	KRT17	Glioblastoma multiforme		Phosphorylation	N	S32	
Q04695	3872	KRT17	Melanoma		Phosphorylation	N	S39	
Q04695	3872	KRT17	Skin cutaneous melanoma		Phosphorylation	N	S39	
Q04695	3872	KRT17	Melanoma		Phosphorylation	N	S44	
Q04695	3872	KRT17	Skin cutaneous melanoma		Phosphorylation	N	S44	
Q04695	3872	KRT17	Breast invasive carcinoma		Phosphorylation	N	S97	
Q04695	3872	KRT17	Glioblastoma multiforme		Phosphorylation	N	S97	
Q04695	3872	KRT17	Hepatocellular carcinoma		Phosphorylation	N	S97	
Q04695	3872	KRT17	Ovarian adenocarcinoma		Phosphorylation	N	S97	
Q04695	3872	KRT17	Pachyonychia congenita		Phosphorylation	N	S97	
Q04695	3872	KRT17	Renal cell carcinoma		Phosphorylation	N	S97	
Q04695	3872	KRT17	Steatocystoma multiplex		Phosphorylation	N	S97	
Q04695	3872	KRT17	Breast invasive carcinoma		Phosphorylation	N	Y98	
Q04695	3872	KRT17	Glioblastoma multiforme		Phosphorylation	N	Y98	
Q04695	3872	KRT17	Hepatocellular carcinoma		Phosphorylation	N	Y98	
Q04695	3872	KRT17	Ovarian adenocarcinoma		Phosphorylation	N	Y98	
Q04695	3872	KRT17	Pachyonychia congenita		Phosphorylation	N	Y98	
Q04695	3872	KRT17	Renal cell carcinoma		Phosphorylation	N	Y98	
Q04695	3872	KRT17	Breast invasive carcinoma		Acetylation	N	K101	
Q04695	3872	KRT17	Glioblastoma multiforme		Acetylation	N	K101	
Q04695	3872	KRT17	Hepatocellular carcinoma		Acetylation	N	K101	
Q04695	3872	KRT17	Ovarian adenocarcinoma		Acetylation	N	K101	
Q04695	3872	KRT17	Pachyonychia congenita		Acetylation	N	K101	
Q04695	3872	KRT17	Renal cell carcinoma		Acetylation	N	K101	
Q04695	3872	KRT17	Breast invasive carcinoma		Ubiquitination	N	K101	
Q04695	3872	KRT17	Glioblastoma multiforme		Ubiquitination	N	K101	
Q04695	3872	KRT17	Hepatocellular carcinoma		Ubiquitination	N	K101	
Q04695	3872	KRT17	Ovarian adenocarcinoma		Ubiquitination	N	K101	
Q04695	3872	KRT17	Pachyonychia congenita		Ubiquitination	N	K101	
Q04695	3872	KRT17	Renal cell carcinoma		Ubiquitination	N	K101	
Q04695	3872	KRT17	Colon adenocarcinoma		Phosphorylation	N	T110	
Q04695	3872	KRT17	Kidney renal papillary cell carcinoma		Phosphorylation	N	T110	
Q04695	3872	KRT17	Pachyonychia congenita		Phosphorylation	N	T110	
Q04695	3872	KRT17	Colon adenocarcinoma		SUMOylation	N	K115	
Q04695	3872	KRT17	Kidney renal papillary cell carcinoma		SUMOylation	N	K115	
Q04695	3872	KRT17	Colon adenocarcinoma		Ubiquitination	N	K115	
Q04695	3872	KRT17	Kidney renal papillary cell carcinoma		Ubiquitination	N	K115	
Q04695	3872	KRT17	Stomach adenocarcinoma		Phosphorylation	N	S132	
Q04695	3872	KRT17	Brain lower grade glioma		Phosphorylation	N	T171	
Q04695	3872	KRT17	Colon adenocarcinoma		Phosphorylation	N	T171	
Q04695	3872	KRT17	Lung squamous cell carcinoma		Phosphorylation	N	T171	
Q04695	3872	KRT17	Brain lower grade glioma		Methylation	N	K172	
Q04695	3872	KRT17	Colon adenocarcinoma		Methylation	N	K172	
Q04695	3872	KRT17	Brain lower grade glioma		SUMOylation	N	K172	
Q04695	3872	KRT17	Colon adenocarcinoma		SUMOylation	N	K172	
Q04695	3872	KRT17	Brain lower grade glioma		Ubiquitination	N	K172	
Q04695	3872	KRT17	Colon adenocarcinoma		Ubiquitination	N	K172	
Q04695	3872	KRT17	Brain lower grade glioma		Phosphorylation	N	T175	
Q04695	3872	KRT17	Colon adenocarcinoma		Phosphorylation	N	T175	
Q04695	3872	KRT17	Lung adenocarcinoma		Phosphorylation	N	Y217	
Q04695	3872	KRT17	Lung adenocarcinoma		SUMOylation	N	K219	
Q04695	3872	KRT17	Lung adenocarcinoma		Ubiquitination	N	K219	
Q04695	3872	KRT17	Lung adenocarcinoma		Ubiquitination	N	K220	
Q04695	3872	KRT17	Hepatocellular carcinoma		Phosphorylation	N	Y260	
Q04695	3872	KRT17	Lung adenocarcinoma		Phosphorylation	N	Y260	
Q04695	3872	KRT17	Non-Hodgkin's lymphoma		Phosphorylation	N	Y260	
Q04695	3872	KRT17	Skin cutaneous melanoma		Phosphorylation	N	Y260	
Q04695	3872	KRT17	Stomach adenocarcinoma		Phosphorylation	N	Y260	
Q04695	3872	KRT17	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Ubiquitination	N	K262	
Q04695	3872	KRT17	Hepatocellular carcinoma		Ubiquitination	N	K262	
Q04695	3872	KRT17	Lung adenocarcinoma		Ubiquitination	N	K262	
Q04695	3872	KRT17	Non-Hodgkin's lymphoma		Ubiquitination	N	K262	
Q04695	3872	KRT17	Skin cutaneous melanoma		Ubiquitination	N	K262	
Q04695	3872	KRT17	Stomach adenocarcinoma		Ubiquitination	N	K262	
Q04695	3872	KRT17	Breast invasive carcinoma		Ubiquitination	N	K269	
Q04695	3872	KRT17	Cervical squamous cell carcinoma and endocervical adenocarcinoma		Ubiquitination	N	K269	
Q04695	3872	KRT17	Non-Hodgkin's lymphoma		Ubiquitination	N	K269	
Q04695	3872	KRT17	Breast invasive carcinoma		Phosphorylation	N	S277	
Q04695	3872	KRT17	Breast invasive carcinoma		Methylation	N	K278	
Q04695	3872	KRT17	Breast invasive carcinoma		SUMOylation	N	K278	
Q04695	3872	KRT17	Breast invasive carcinoma		Ubiquitination	N	K278	
Q04695	3872	KRT17	Bladder urothelial carcinoma		Phosphorylation	N	S323	
Q04695	3872	KRT17	Melanoma		Phosphorylation	N	S323	
Q04695	3872	KRT17	Hepatocellular carcinoma		Phosphorylation	N	Y367	
Q04695	3872	KRT17	Uterine corpus endometrial carcinoma		Phosphorylation	N	Y367	
Q04695	3872	KRT17	Hepatocellular carcinoma		Ubiquitination	N	K374	
Q04695	3872	KRT17	Pachyonychia congenita		Phosphorylation	N	T383	
Q04695	3872	KRT17	Skin cutaneous melanoma		Phosphorylation	N	T383	
Q04695	3872	KRT17	Stomach adenocarcinoma		Phosphorylation	N	T383	
Q04695	3872	KRT17	Pachyonychia congenita		Phosphorylation	N	Y384	
Q04695	3872	KRT17	Skin cutaneous melanoma		Phosphorylation	N	Y384	
Q04695	3872	KRT17	Stomach adenocarcinoma		Phosphorylation	N	Y384	
Q04695	3872	KRT17	Lung adenocarcinoma		Phosphorylation	N	Y398	
Q04695	3872	KRT17	Skin cutaneous melanoma		Phosphorylation	N	Y398	
Q04695	3872	KRT17	Lung adenocarcinoma		SUMOylation	N	K399	
Q04695	3872	KRT17	Skin cutaneous melanoma		SUMOylation	N	K399	
Q04695	3872	KRT17	Lung adenocarcinoma		Ubiquitination	N	K399	
Q04695	3872	KRT17	Skin cutaneous melanoma		Ubiquitination	N	K399	
Q04695	3872	KRT17	Lung adenocarcinoma		SUMOylation	N	K400	
Q04695	3872	KRT17	Skin cutaneous melanoma		SUMOylation	N	K400	
Q04695	3872	KRT17	Lung adenocarcinoma		Ubiquitination	N	K400	
Q04695	3872	KRT17	Skin cutaneous melanoma		Ubiquitination	N	K400	
Q04695	3872	KRT17	Skin cutaneous melanoma		Phosphorylation	N	T410	
Q04695	3872	KRT17	Breast adenocarcinoma		SUMOylation	N	K419	
Q04695	3872	KRT17	Skin cutaneous melanoma		SUMOylation	N	K419	
Q04695	3872	KRT17	Breast adenocarcinoma		Ubiquitination	N	K419	
Q04695	3872	KRT17	Skin cutaneous melanoma		Ubiquitination	N	K419	
Q04695	3872	KRT17	Psoriasis	keratinocytes	Serine phosphorylation	U	S44	37497003
Q04695	3872	KRT17	Lung cancer		Serine phosphorylation	U	S13	35116305
Q04695	3872	KRT17	Lung cancer		Serine phosphorylation	U	S24	35116305
Q04695	3872	KRT17	Lung cancer		Serine phosphorylation	U	S32	35116305
Q04695	3872	KRT17	Lung cancer		Serine phosphorylation	U	S39	35116305
